Gu S. Roh

Chinju, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications

Intrahepatic Klebsiella pneumoniae is associated with host cellular dysfunction in metabolic dysfunction-associated steatohepatitis.

Intrahepatic Klebsiella pneumoniae is associated with host cellular dysfunction in metabolic dysfunction-associated steatohepatitis.

Journal: Microbiology spectrum
Published: August 04, 2026

Emerging role of low-frequency somatic mutations in cancer relapse: from early detection to precision oncology.

Emerging role of low-frequency somatic mutations in cancer relapse: from early detection to precision oncology.

Journal: Frontiers in oncology
Published: December 21, 2025

Lipocalin-2 deficiency attenuates kainic acid-induced hippocampal cell death in a high-fat diet-fed diabetic mice.

Lipocalin-2 deficiency attenuates kainic acid-induced hippocampal cell death in a high-fat diet-fed diabetic mice.

Journal: Metabolic brain disease
Published: October 27, 2025

Dapagliflozin for metabolic dysfunction-associated steatohepatitis with fibrosis: a promising therapeutic agent in biopsy-diagnosed patients.

Dapagliflozin for metabolic dysfunction-associated steatohepatitis with fibrosis: a promising therapeutic agent in biopsy-diagnosed patients.

Journal: Hepatobiliary surgery and nutrition
Published: September 22, 2025

Obesity Aggravates Status Epilepticus Through Lipocalin-2-mediated Inflammation and Necroptosis.

Obesity Aggravates Status Epilepticus Through Lipocalin-2-mediated Inflammation and Necroptosis.

Journal: Neurochemical research
Published: September 12, 2025

Myeloid-specific STAT3 deletion modulates molecular activation of hippocampal microglia without morphological remodeling.

Myeloid-specific STAT3 deletion modulates molecular activation of hippocampal microglia without morphological remodeling.

Journal: Biochemical and biophysical research communications
Published: August 26, 2025

Myeloid-Specific STAT3 Deletion Aggravates Liver Fibrosis in Mice Fed a Methionine- and Choline-Deficient Diet via Upregulation of Hepatocyte-Derived Lipocalin-2.

Myeloid-Specific STAT3 Deletion Aggravates Liver Fibrosis in Mice Fed a Methionine- and Choline-Deficient Diet via Upregulation of Hepatocyte-Derived Lipocalin-2.

Journal: Cells
Published: August 20, 2025

Redox regulation by sulfiredoxin-1: bridging cysteine oxidation and liver disease therapeutics.

Redox regulation by sulfiredoxin-1: bridging cysteine oxidation and liver disease therapeutics.

Journal: Experimental & molecular medicine
Published: April 21, 2025

Erratum: Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice.

Erratum: Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice.

Journal: Hepatology (Baltimore, Md.)
Published: March 27, 2025

Carbon tetrachloride does not promote hepatic fibrosis in ob/ob mice via downregulation of lipocalin-2 protein.

Carbon tetrachloride does not promote hepatic fibrosis in ob/ob mice via downregulation of lipocalin-2 protein.

Journal: Redox biology
Published: November 23, 2024

Combined Esculentin-2CHa Fusion Protein-Coated Au Nanoparticles for Effective Against Non-Alcoholic Fatty Liver Disease in Mice Model.

Combined Esculentin-2CHa Fusion Protein-Coated Au Nanoparticles for Effective Against Non-Alcoholic Fatty Liver Disease in Mice Model.

Journal: International journal of nanomedicine
Published: September 24, 2024

Long-Lasting Exendin-4-Coated Gold Nanoparticles: Synthesis and In Vivo Evaluation of Hypoglycemic Activity.

Long-Lasting Exendin-4-Coated Gold Nanoparticles: Synthesis and In Vivo Evaluation of Hypoglycemic Activity.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 15, 2024
Showing 1-12 of 111

Last Updated: 09/26/2026